Clinical Trial Update: Irritation and Sensitization Potential of Repeat Applications of Rotigotine Patch [Phase 1]

View source ↗

Summary

A Phase 1 study evaluated the irritation and skin sensitization potential of repeat applications of the rotigotine transdermal patch; the trial is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease
• Restless Legs Syndrome

Drugs mentioned

• Rotigotine patch (Neupro) (rotigotine)

Snippet

Sponsor: Inflamax Research Incorporated | Conditions: Bioequivalence - Irritation and Sensitization Potential of Transdermal Patch | Phase 1 | Status: COMPLETED